Sergio Armando Covarrubias-Castillo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sergio Armando Covarrubias-Castillo has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Daniel Alejandro Muñoz-Chacón
2 shared publications- Asit Baran Biswas
University of Leicester
1 shared publication Edson Ramsés Becerra-Alvarez
1 shared publicationFrancisco José Barbosa-Camacho
1 shared publication- Gabriela Navarro Machuca
Servicio de Psiquiatría del Hospital Civil Fray Antonio Alcalde, Guadalajara C.P. 44280, JA, Mexico
1 shared publication - Gian Maria Galeazzi
Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy
1 shared publication
Latest Publications
- Open Access
- 12 September 2025
- Published by Royal College of Psychiatrists in BJPsych Advances
- Vol. 31 (6) , 322-324
Liaison psychiatry special issue (part 1)
SUMMARY: This editorial introduces the first of two special issues of BJPsych Advances devoted to liaison psychiatry, reflecting collaborative healthcare for patients presenting with both physical and mental health conditions, whether in acute general hospitals, out-patient clinics, in-patient wards or accident and emergency departments.
- 12 September 2025
- Published by Royal College of Psychiatrists in BJPsych Advances
- Vol. 31 (6) , 322-324
Open AccessLiaison psychiatry special issue (part 1)
SUMMARY: This editorial introduces the first of two special issues of BJPsych Advances devoted to liaison psychiatry, reflecting collaborative healthcare for patients presenting with both physical and mental health conditions, whether in acute general hospitals, out-patient clinics, in-patient wards or accident and emergency departments.
- 13 May 2025
- Published by Royal College of Psychiatrists in BJPsych Advances
- Vol. 31 (4) , 223-225
Of polypharmacy and voids: pharmacotherapy in borderline personality disorder
SUMMARY: Despite being the most prevalent personality disorder, borderline personality disorder remains a diagnosis with many unanswered questions, particularly concerning pharmacological management. Although many clinical practice guidelines suggest not prescribing medication unless there are significant clinical comorbidities, it is one of the psychiatric diagnoses with the highest rates of polypharmacy. This commentary on a BJPsych Advances article aims to raise clinical questions regarding the voids of knowledge and the appropriateness of medicating and, perhaps, overmedicating in this particular group.
- 13 May 2025
- Published by Royal College of Psychiatrists in BJPsych Advances
- Vol. 31 (4) , 223-225
Of polypharmacy and voids: pharmacotherapy in borderline personality disorder
SUMMARY: Despite being the most prevalent personality disorder, borderline personality disorder remains a diagnosis with many unanswered questions, particularly concerning pharmacological management. Although many clinical practice guidelines suggest not prescribing medication unless there are significant clinical comorbidities, it is one of the psychiatric diagnoses with the highest rates of polypharmacy. This commentary on a BJPsych Advances article aims to raise clinical questions regarding the voids of knowledge and the appropriateness of medicating and, perhaps, overmedicating in this particular group.
- Open Access
- 1 January 2024
- Published by GRAPHIMEDIC SA DE CV in Salud Jalisco
- Vol. 11 (1) , 44-49
Síndrome de neurotoxicidad irreversible secundario a litio (SILENT) y trastorno bipolar: reporte de caso
Introducción: las alteraciones primordiales del síndrome de neurotoxicidad irreversible secundario a litio (SILENT) son trastornos cerebelosos de tipo vermiano, síndrome extrapiramidal persistente, disfunción del tallo cerebral y demencia. Se pretende comunicar esta complicación rara del consumo de litio, a propósito de un caso con trastorno bipolar tipo 1. Caso clínico: se trata de paciente femenino de 47 años, previamente diagnosticada con trastorno bipolar tipo 1 y tratada con litio a dosis desconocidas. Ingresada a medicina interna por intoxicación con litio moderado-grave que persiste con secuelas neurológicas y psiquiátricas por más de dos meses desde su ingreso. Se realizan estudios de laboratorio, imagen y pruebas cognitivas que demuestran cambios anatómicos y funcionales de predominio frontal, así como evidente deterioro cognitivo. Conclusión: destacamos la importancia del adecuado control terapéutico y continua evaluación de niveles séricos de litio para prevenir la aparición de niveles tóxicos de litio, procurando evitar la aparición de secuelas neurológicas potencialmente permanentes, con alto riesgo de generar grave disfunción.
- 1 January 2024
- Published by GRAPHIMEDIC SA DE CV in Salud Jalisco
- Vol. 11 (1) , 44-49
Open AccessSíndrome de neurotoxicidad irreversible secundario a litio (SILENT) y trastorno bipolar: reporte de caso
Introducción: las alteraciones primordiales del síndrome de neurotoxicidad irreversible secundario a litio (SILENT) son trastornos cerebelosos de tipo vermiano, síndrome extrapiramidal persistente, disfunción del tallo cerebral y demencia. Se pretende comunicar esta complicación rara del consumo de litio, a propósito de un caso con trastorno bipolar tipo 1. Caso clínico: se trata de paciente femenino de 47 años, previamente diagnosticada con trastorno bipolar tipo 1 y tratada con litio a dosis desconocidas. Ingresada a medicina interna por intoxicación con litio moderado-grave que persiste con secuelas neurológicas y psiquiátricas por más de dos meses desde su ingreso. Se realizan estudios de laboratorio, imagen y pruebas cognitivas que demuestran cambios anatómicos y funcionales de predominio frontal, así como evidente deterioro cognitivo. Conclusión: destacamos la importancia del adecuado control terapéutico y continua evaluación de niveles séricos de litio para prevenir la aparición de niveles tóxicos de litio, procurando evitar la aparición de secuelas neurológicas potencialmente permanentes, con alto riesgo de generar grave disfunción.
- Open Access
Toxoplasmosis Is More Frequent in Schizophrenia Patients Than in the General Population in Mexico and Is Not Associated with More Severe Course of Schizophrenia Measured with the Brief Psychiatric Rating Scale
Toxoplasmosis is a disease, which was discovered in 1908, caused by the intracellular parasite Toxoplasma gondii. T. gondii infects neuronal, glial, and muscle cells, and chronic infections are characterized by the presence of cysts, in the brain and muscle cells, formed by bradyzoites. T. gondii is capable of synthesizing L-DOPA, a precursor of dopamine. Dopamine is a neurotransmitter that is key in the etiology of neuropsychological disorders such as schizophrenia. Previous studies have shown high levels of IgG Toxoplasma antibodies in schizophrenia patients. Many published studies show that the prevalence of toxoplasmosis is higher in schizophrenia patients. In this study, we aimed to identify the prevalence of Toxoplasma infection in patients with schizophrenia and the relationships between, sociodemographic factors and the Brief Psychiatric Rating Scale. A total of 27 schizophrenic patients were included and IgG anti-T. gondii was determined in serum samples by ELISA. The Brief Psychiatric Rating Scale, sociodemographic factors were associated with seropositivity. We found that the prevalence of Toxoplasma antibodies was 51.7%. In the Brief Psychiatric Rating Scale, statistical significant association (p = 0.024) was found in Item 13 which is related to motor retardation, however, the association turned non-significant after of correction for multiple tests or after of analyzed with a logistic regression p = 0.059, odds ratio (OR) = 2.316 with a 95% confidence interval [0.970 to 5.532]. Other association was not found between toxoplasmosis and others factors. The prevalence of toxoplasmosis on our population under study was significantly higher than that reported by general population or other group of Mexican schizophrenia patients.
Open AccessToxoplasmosis Is More Frequent in Schizophrenia Patients Than in the General Population in Mexico and Is Not Associated with More Severe Course of Schizophrenia Measured with the Brief Psychiatric Rating Scale
Toxoplasmosis is a disease, which was discovered in 1908, caused by the intracellular parasite Toxoplasma gondii. T. gondii infects neuronal, glial, and muscle cells, and chronic infections are characterized by the presence of cysts, in the brain and muscle cells, formed by bradyzoites. T. gondii is capable of synthesizing L-DOPA, a precursor of dopamine. Dopamine is a neurotransmitter that is key in the etiology of neuropsychological disorders such as schizophrenia. Previous studies have shown high levels of IgG Toxoplasma antibodies in schizophrenia patients. Many published studies show that the prevalence of toxoplasmosis is higher in schizophrenia patients. In this study, we aimed to identify the prevalence of Toxoplasma infection in patients with schizophrenia and the relationships between, sociodemographic factors and the Brief Psychiatric Rating Scale. A total of 27 schizophrenic patients were included and IgG anti-T. gondii was determined in serum samples by ELISA. The Brief Psychiatric Rating Scale, sociodemographic factors were associated with seropositivity. We found that the prevalence of Toxoplasma antibodies was 51.7%. In the Brief Psychiatric Rating Scale, statistical significant association (p = 0.024) was found in Item 13 which is related to motor retardation, however, the association turned non-significant after of correction for multiple tests or after of analyzed with a logistic regression p = 0.059, odds ratio (OR) = 2.316 with a 95% confidence interval [0.970 to 5.532]. Other association was not found between toxoplasmosis and others factors. The prevalence of toxoplasmosis on our population under study was significantly higher than that reported by general population or other group of Mexican schizophrenia patients.
- Open Access
- 5 October 2020
- Published by Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz in Salud mental
- Vol. 43 (5) , 227-233
Association between Burnout Syndrome and medical training by specialty in first-year residents
Introduction. Burnout syndrome (BOS) comprises emotional exhaustion, depersonalization, and reduced personal accomplishment in those affected. Instruments such as the Maslach Burnout Inventory (MBI) can help to identify those affected. Physicians in training have been described as an at-risk group for this syndrome. Objective. Describe the association between BOS and medical training by specialty in first-year residents. Method. This is a cross-sectional analytical study of specialty residents at the Hospital Civil de Guadalajara. Sociodemographic data were obtained and the MBI was administered to identify BOS. Samples were compared, and a comparative analysis performed to identify factors associated with BOS. Results. Eighty-eight residents were included, with 21.6% (n = 19) presenting BOS, 53.4% displaying emotional exhaustion (n = 47), 53.7% showing depersonalization (n = 47), and 39.8% reduced personal accomplishment (n = 35). Presenting BOS was not associated with sociodemographic characteristics or type of specialty. Work hours (ro = .229, p = .032), and a higher number of on-call hours/week (ro = .34, p = .001) were associated with higher BOS. Discussion and conclusion. The prevalence of BOS was lower than expected. Over half scored for emotional exhaustion and depersonalization, which could be explained by a self-reporting bias. There was no association between the group/type of specialty and BOS. This study creates new knowledge that works as an institutional situational diagnosis, helps to determine the scope of the problem, and encourages to consider the contributing factors to its origin and maintenance.
- 5 October 2020
- Published by Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz in Salud mental
- Vol. 43 (5) , 227-233
Open AccessAssociation between Burnout Syndrome and medical training by specialty in first-year residents
Introduction. Burnout syndrome (BOS) comprises emotional exhaustion, depersonalization, and reduced personal accomplishment in those affected. Instruments such as the Maslach Burnout Inventory (MBI) can help to identify those affected. Physicians in training have been described as an at-risk group for this syndrome. Objective. Describe the association between BOS and medical training by specialty in first-year residents. Method. This is a cross-sectional analytical study of specialty residents at the Hospital Civil de Guadalajara. Sociodemographic data were obtained and the MBI was administered to identify BOS. Samples were compared, and a comparative analysis performed to identify factors associated with BOS. Results. Eighty-eight residents were included, with 21.6% (n = 19) presenting BOS, 53.4% displaying emotional exhaustion (n = 47), 53.7% showing depersonalization (n = 47), and 39.8% reduced personal accomplishment (n = 35). Presenting BOS was not associated with sociodemographic characteristics or type of specialty. Work hours (ro = .229, p = .032), and a higher number of on-call hours/week (ro = .34, p = .001) were associated with higher BOS. Discussion and conclusion. The prevalence of BOS was lower than expected. Over half scored for emotional exhaustion and depersonalization, which could be explained by a self-reporting bias. There was no association between the group/type of specialty and BOS. This study creates new knowledge that works as an institutional situational diagnosis, helps to determine the scope of the problem, and encourages to consider the contributing factors to its origin and maintenance.